Genevieve Martin
@genevieveemart1.bsky.social
Australian doctor and scientist. PhD in HIV immunology. #IDSky
Brilliant to speak at ANZAN ASM this week on neurological infections in Australia.
Enjoyed hearing from @runningmadprof.bsky.social and learning from the thoughtful discussions throughout the conference.
#ANZAN
Enjoyed hearing from @runningmadprof.bsky.social and learning from the thoughtful discussions throughout the conference.
#ANZAN
Who’s at ANZAN ASM this year?
I’ll be presenting on emerging neurological infections (Day 2) and leading interactive cases in challenging neuro-infectious diseases (Day 4).
More: www.anzanasm.com.au #ANZAN
I’ll be presenting on emerging neurological infections (Day 2) and leading interactive cases in challenging neuro-infectious diseases (Day 4).
More: www.anzanasm.com.au #ANZAN
June 25, 2026 at 6:49 AM
Brilliant to speak at ANZAN ASM this week on neurological infections in Australia.
Enjoyed hearing from @runningmadprof.bsky.social and learning from the thoughtful discussions throughout the conference.
#ANZAN
Enjoyed hearing from @runningmadprof.bsky.social and learning from the thoughtful discussions throughout the conference.
#ANZAN
Reposted by Genevieve Martin
New research shows getting your annual flu vaccine can protect you from seasonal influenza strains and prime your immune system to respond to future strains, even some that emerge decades later.
Find out more 🔗 https://bit.ly/4saTNBw
Find out more 🔗 https://bit.ly/4saTNBw
Looking back to protect the future: New insights into influenza immunity
A new study from the Doherty Institute shows that seasonal influenza vaccination does more than protect against viruses circulating that year; it can also prime the immune system to respond to future strains, including some that emerge decades later.
bit.ly
April 1, 2026 at 8:00 PM
New research shows getting your annual flu vaccine can protect you from seasonal influenza strains and prime your immune system to respond to future strains, even some that emerge decades later.
Find out more 🔗 https://bit.ly/4saTNBw
Find out more 🔗 https://bit.ly/4saTNBw
Reposted by Genevieve Martin
The new issue of #ScienceTranslationalMedicine is out!
Featuring the winner of the 2026 BII & Science Translational Prize for Innovations in Women's Health, a "time capsule" of samples sheds new light on the breadth of flu vaccine immunity, and more. https://scim.ag/4taZbVW
Featuring the winner of the 2026 BII & Science Translational Prize for Innovations in Women's Health, a "time capsule" of samples sheds new light on the breadth of flu vaccine immunity, and more. https://scim.ag/4taZbVW
April 1, 2026 at 9:00 PM
The new issue of #ScienceTranslationalMedicine is out!
Featuring the winner of the 2026 BII & Science Translational Prize for Innovations in Women's Health, a "time capsule" of samples sheds new light on the breadth of flu vaccine immunity, and more. https://scim.ag/4taZbVW
Featuring the winner of the 2026 BII & Science Translational Prize for Innovations in Women's Health, a "time capsule" of samples sheds new light on the breadth of flu vaccine immunity, and more. https://scim.ag/4taZbVW
Reposted by Genevieve Martin
Extremely privileged to have our study featured on the issue cover which we designed with the latented team @scistories.bsky.social #ScienceTranslationalMedicine!
@katherinekedz.bsky.social
@thedohertyinst.bsky.social
@katherinekedz.bsky.social
@thedohertyinst.bsky.social
The new issue of #ScienceTranslationalMedicine is out!
Featuring the winner of the 2026 BII & Science Translational Prize for Innovations in Women's Health, a "time capsule" of samples sheds new light on the breadth of flu vaccine immunity, and more. https://scim.ag/4taZbVW
Featuring the winner of the 2026 BII & Science Translational Prize for Innovations in Women's Health, a "time capsule" of samples sheds new light on the breadth of flu vaccine immunity, and more. https://scim.ag/4taZbVW
April 2, 2026 at 12:50 AM
Extremely privileged to have our study featured on the issue cover which we designed with the latented team @scistories.bsky.social #ScienceTranslationalMedicine!
@katherinekedz.bsky.social
@thedohertyinst.bsky.social
@katherinekedz.bsky.social
@thedohertyinst.bsky.social
Reposted by Genevieve Martin
IFN-gene signatures in #Bcells following #influenza A and B virus infection and influenza #vaccination 👉 doi.org/10.1038/s44321-026-00395-8
By W. Zhang, @katherinekedz.bsky.social , T. Nguyen & colleagues @unimelb.edu.au @thedohertyinst.bsky.social
By W. Zhang, @katherinekedz.bsky.social , T. Nguyen & colleagues @unimelb.edu.au @thedohertyinst.bsky.social
March 9, 2026 at 8:40 PM
IFN-gene signatures in #Bcells following #influenza A and B virus infection and influenza #vaccination 👉 doi.org/10.1038/s44321-026-00395-8
By W. Zhang, @katherinekedz.bsky.social , T. Nguyen & colleagues @unimelb.edu.au @thedohertyinst.bsky.social
By W. Zhang, @katherinekedz.bsky.social , T. Nguyen & colleagues @unimelb.edu.au @thedohertyinst.bsky.social
Thrilled to share that I have been awarded the Australian and New Zealand Society for Immunology (ASI) Breakthrough Immunology Award for exciting research into flavivirus encephalitis with @katherinekedz.bsky.social @thedohertyinst.bsky.social
www.linkedin.com/posts/the-pe...
www.linkedin.com/posts/the-pe...
December 8, 2025 at 3:48 AM
Thrilled to share that I have been awarded the Australian and New Zealand Society for Immunology (ASI) Breakthrough Immunology Award for exciting research into flavivirus encephalitis with @katherinekedz.bsky.social @thedohertyinst.bsky.social
www.linkedin.com/posts/the-pe...
www.linkedin.com/posts/the-pe...
Reposted by Genevieve Martin
Why do some people get seriously ill while others don't? Our new study in @pnas.org investigated how a population of memory T cells influence #COVID severity
Read the paper: go.unimelb.edu.au/4zkp
Or our article here: go.unimelb.edu.au/2zkp
@katherinekedz.bsky.social @thedohertyinst.bsky.social
Read the paper: go.unimelb.edu.au/4zkp
Or our article here: go.unimelb.edu.au/2zkp
@katherinekedz.bsky.social @thedohertyinst.bsky.social
HLA-B*15:01-positive severe COVID-19 patients lack CD8+ T cell pools with highly expanded public clonotypes | PNAS
Understanding host factors driving asymptomatic versus severe disease outcomes is
of key importance if we are to control emerging and re-emerging v...
go.unimelb.edu.au
September 5, 2025 at 8:14 AM
Why do some people get seriously ill while others don't? Our new study in @pnas.org investigated how a population of memory T cells influence #COVID severity
Read the paper: go.unimelb.edu.au/4zkp
Or our article here: go.unimelb.edu.au/2zkp
@katherinekedz.bsky.social @thedohertyinst.bsky.social
Read the paper: go.unimelb.edu.au/4zkp
Or our article here: go.unimelb.edu.au/2zkp
@katherinekedz.bsky.social @thedohertyinst.bsky.social
Reposted by Genevieve Martin
Read the study in full: doi.org/10.1186/s128...
@hepbvoicesau.bsky.social @hepatitisaustralia.bsky.social @genevieveemart1.bsky.social @thedohertyinst.bsky.social
@hepbvoicesau.bsky.social @hepatitisaustralia.bsky.social @genevieveemart1.bsky.social @thedohertyinst.bsky.social
July 14, 2025 at 4:30 AM
Reposted by Genevieve Martin
NEW STUDY | Menzies’ researchers have led the largest-ever study of people living with a unique strain of chronic hepatitis B (C4 hep B), uncovering significant impacts on liver health. Learn more about these findings and the work of the Hep B PAST Plus program: www.menzies.edu.au/page/News_an...
July 14, 2025 at 4:30 AM
NEW STUDY | Menzies’ researchers have led the largest-ever study of people living with a unique strain of chronic hepatitis B (C4 hep B), uncovering significant impacts on liver health. Learn more about these findings and the work of the Hep B PAST Plus program: www.menzies.edu.au/page/News_an...
Thrilled to share our new research led by Jane Davies @menziesresearch.bsky.social on First Nations people in the NT living with chronic hepatitis B. An important study that could inform better care:
doi.org/10.1186/s128...
#idsky #MedSky #HepSky #LiverSky
doi.org/10.1186/s128...
#idsky #MedSky #HepSky #LiverSky
July 2, 2025 at 1:31 AM
Thrilled to share our new research led by Jane Davies @menziesresearch.bsky.social on First Nations people in the NT living with chronic hepatitis B. An important study that could inform better care:
doi.org/10.1186/s128...
#idsky #MedSky #HepSky #LiverSky
doi.org/10.1186/s128...
#idsky #MedSky #HepSky #LiverSky
Excited to have contributed to the updated version of the Tropical Health Orientation Manual which has just been published by @menziesresearch.bsky.social 🐊🧫😷 #idsky
Are you a health practitioner working in northern Australia? The Tropical Health Orientation Manual (THOM) 2025 provides best practice advice for diagnosis, identification & treatment of conditions specific to the tropical north. Download: tinyurl.com/ahw6jyk8
July 1, 2025 at 11:59 PM
Excited to have contributed to the updated version of the Tropical Health Orientation Manual which has just been published by @menziesresearch.bsky.social 🐊🧫😷 #idsky
Reposted by Genevieve Martin
particularly acute kidney injury, bone marrow suppression, and severe cutaneous reactions, affecting over 50% of patients exposed. Notably, 44% required cessation or dose reduction due to toxicity
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
@idsainfo.bsky.social
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
@idsainfo.bsky.social
Low-Dose Trimethoprim/Sulfamethoxazole for Melioidosis Eradication Therapy: A Clinically Tolerable Alternative.
www.sciencedirect.com
June 21, 2025 at 4:45 AM
particularly acute kidney injury, bone marrow suppression, and severe cutaneous reactions, affecting over 50% of patients exposed. Notably, 44% required cessation or dose reduction due to toxicity
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
@idsainfo.bsky.social
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
@idsainfo.bsky.social
The wet season has arrived! ⛈️ Sharing our two new papers on clinical aspects of melioidosis 🧫 in the Top End of Australia 🐊🇦🇺 — work done with Prof Bart Currie and Prof Jane Davies at Menzies School of Health Research #IDSky
December 8, 2024 at 4:35 AM
The wet season has arrived! ⛈️ Sharing our two new papers on clinical aspects of melioidosis 🧫 in the Top End of Australia 🐊🇦🇺 — work done with Prof Bart Currie and Prof Jane Davies at Menzies School of Health Research #IDSky